These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 608570)

  • 41. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
    Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
    Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A practical guide to the nonsurgical treatment of gallstones.
    Maudgal DP; Northfield TC
    Drugs; 1991 Feb; 41(2):185-92. PubMed ID: 1709849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The non-operative management of gallstones.
    Sali A; Iser J
    Aust N Z J Surg; 1978 Oct; 48(5):484-8. PubMed ID: 285693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical-chemical properties of chenodeoxycholic acid and ursodeoxycholic acid.
    Hisadome T; Nakama T; Itoh H; Furusawa T
    Gastroenterol Jpn; 1980; 15(3):257-63. PubMed ID: 7399224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F; Breto M; del Val A; Berenguer J
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
    Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
    Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.
    Leuschner U; Leuschner M; Sieratzki J; Kurtz W; Hübner K
    Dig Dis Sci; 1985 Jul; 30(7):642-9. PubMed ID: 4006646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged administration of bile salts for gallstone dissolution and its effect on rectal epithelial cell proliferation.
    Deschner EE; Hallak A; Rozen P; Gilat T
    Dig Dis Sci; 1987 Sep; 32(9):991-6. PubMed ID: 3622194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gallstone solubilizers].
    Ighimi H
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1170-3. PubMed ID: 6503981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of fatty acid esters of cheno- and ursodeoxycholic acids on gallstone formation in hamsters.
    Kritchevsky D; Klurfeld DM; Sirtori C
    Pharmacol Res Commun; 1986 Nov; 18(11):997-1002. PubMed ID: 3797448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids.
    Maton PN; Ellis HJ; Higgins MJ; Dowling RH
    Eur J Clin Invest; 1980 Aug; 10(4):325-32. PubMed ID: 6775960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action.
    Maton PN; Murphy GM; Dowling RH
    Lancet; 1977 Dec 24-31; 2(8052-8053):1297-301. PubMed ID: 74722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.